Director, ADME/PK
Dyne Therapeutics
Waltham, Massachusetts
Babak Basiri is currently the Director of ADME/PK at Dyne Therapeutics. Prior to Dyne, he has worked as a DMPK Scientist with Alnylam Pharmaceuticals and Amgen. In his various roles, he has applied knowledge in drug metabolism, pharmacokinetics, pharmacodynamics, PK/PD modeling, and bioanalytical principles to various oligonucleotide and oligonucleotide-protein conjugate programs.
Babak holds a Ph.D. from the University of Georgia, and a Masters in Biological Sciences from the University of Delaware.
Disclosure information not submitted.
Keynote: New Approach Methods – From Ugly Ducklings to Beautiful Swans
Tuesday, May 12, 2026
1:00 PM - 2:00 PM PT